A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Omeprazole in Healthy Male and Female Adults.
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2012
At a glance
- Drugs Sucroferric oxyhydroxide (Primary) ; Omeprazole
- Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Hyperphosphataemia; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- 09 Dec 2011 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 09 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 09 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.